Copyright Reports & Markets. All rights reserved.

Global and China Uterine Fibroid Treatment Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Uterine Fibroid Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Endometrial Ablation
    • 1.2.3 MRI Guided Procedures
    • 1.2.4 Hysterectomy
    • 1.2.5 Myomectomy
    • 1.2.6 Uterine Artery Embolization
    • 1.2.7 Radiofrequency Ablation
    • 1.2.8 Others
  • 1.3 Market by Application
    • 1.3.1 Global Uterine Fibroid Treatment Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Uterine Fibroid Treatment Market Perspective (2015-2026)
  • 2.2 Global Uterine Fibroid Treatment Growth Trends by Regions
    • 2.2.1 Uterine Fibroid Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Uterine Fibroid Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Uterine Fibroid Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Uterine Fibroid Treatment Players by Market Size
    • 3.1.1 Global Top Uterine Fibroid Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Uterine Fibroid Treatment Revenue Market Share by Players (2015-2020)
  • 3.2 Global Uterine Fibroid Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Uterine Fibroid Treatment Revenue
  • 3.4 Global Uterine Fibroid Treatment Market Concentration Ratio
    • 3.4.1 Global Uterine Fibroid Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Uterine Fibroid Treatment Revenue in 2019
  • 3.5 Key Players Uterine Fibroid Treatment Area Served
  • 3.6 Key Players Uterine Fibroid Treatment Product Solution and Service
  • 3.7 Date of Enter into Uterine Fibroid Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Uterine Fibroid Treatment Breakdown Data by Type (2015-2026)

  • 4.1 Global Uterine Fibroid Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Uterine Fibroid Treatment Forecasted Market Size by Type (2021-2026)

5 Uterine Fibroid Treatment Breakdown Data by Application (2015-2026)

  • 5.1 Global Uterine Fibroid Treatment Historic Market Size by Application (2015-2020)
  • 5.2 Global Uterine Fibroid Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Uterine Fibroid Treatment Market Size (2015-2026)
  • 6.2 North America Uterine Fibroid Treatment Market Size by Type (2015-2020)
  • 6.3 North America Uterine Fibroid Treatment Market Size by Application (2015-2020)
  • 6.4 North America Uterine Fibroid Treatment Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Uterine Fibroid Treatment Market Size (2015-2026)
  • 7.2 Europe Uterine Fibroid Treatment Market Size by Type (2015-2020)
  • 7.3 Europe Uterine Fibroid Treatment Market Size by Application (2015-2020)
  • 7.4 Europe Uterine Fibroid Treatment Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Uterine Fibroid Treatment Market Size (2015-2026)
  • 8.2 China Uterine Fibroid Treatment Market Size by Type (2015-2020)
  • 8.3 China Uterine Fibroid Treatment Market Size by Application (2015-2020)
  • 8.4 China Uterine Fibroid Treatment Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Uterine Fibroid Treatment Market Size (2015-2026)
  • 9.2 Japan Uterine Fibroid Treatment Market Size by Type (2015-2020)
  • 9.3 Japan Uterine Fibroid Treatment Market Size by Application (2015-2020)
  • 9.4 Japan Uterine Fibroid Treatment Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Uterine Fibroid Treatment Market Size (2015-2026)
  • 10.2 Southeast Asia Uterine Fibroid Treatment Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Uterine Fibroid Treatment Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Uterine Fibroid Treatment Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Blue Endo
    • 11.1.1 Blue Endo Company Details
    • 11.1.2 Blue Endo Business Overview
    • 11.1.3 Blue Endo Uterine Fibroid Treatment Introduction
    • 11.1.4 Blue Endo Revenue in Uterine Fibroid Treatment Business (2015-2020))
    • 11.1.5 Blue Endo Recent Development
  • 11.2 Boston Scientific Corporation
    • 11.2.1 Boston Scientific Corporation Company Details
    • 11.2.2 Boston Scientific Corporation Business Overview
    • 11.2.3 Boston Scientific Corporation Uterine Fibroid Treatment Introduction
    • 11.2.4 Boston Scientific Corporation Revenue in Uterine Fibroid Treatment Business (2015-2020)
    • 11.2.5 Boston Scientific Corporation Recent Development
  • 11.3 CooperSurgical, Inc.
    • 11.3.1 CooperSurgical, Inc. Company Details
    • 11.3.2 CooperSurgical, Inc. Business Overview
    • 11.3.3 CooperSurgical, Inc. Uterine Fibroid Treatment Introduction
    • 11.3.4 CooperSurgical, Inc. Revenue in Uterine Fibroid Treatment Business (2015-2020)
    • 11.3.5 CooperSurgical, Inc. Recent Development
  • 11.4 KARL STORZ SE & Co. KG
    • 11.4.1 KARL STORZ SE & Co. KG Company Details
    • 11.4.2 KARL STORZ SE & Co. KG Business Overview
    • 11.4.3 KARL STORZ SE & Co. KG Uterine Fibroid Treatment Introduction
    • 11.4.4 KARL STORZ SE & Co. KG Revenue in Uterine Fibroid Treatment Business (2015-2020)
    • 11.4.5 KARL STORZ SE & Co. KG Recent Development
  • 11.5 Myovant Sciences (Sumitovant Biopharma Ltd.)
    • 11.5.1 Myovant Sciences (Sumitovant Biopharma Ltd.) Company Details
    • 11.5.2 Myovant Sciences (Sumitovant Biopharma Ltd.) Business Overview
    • 11.5.3 Myovant Sciences (Sumitovant Biopharma Ltd.) Uterine Fibroid Treatment Introduction
    • 11.5.4 Myovant Sciences (Sumitovant Biopharma Ltd.) Revenue in Uterine Fibroid Treatment Business (2015-2020)
    • 11.5.5 Myovant Sciences (Sumitovant Biopharma Ltd.) Recent Development
  • 11.6 Halt Medical, Inc.
    • 11.6.1 Halt Medical, Inc. Company Details
    • 11.6.2 Halt Medical, Inc. Business Overview
    • 11.6.3 Halt Medical, Inc. Uterine Fibroid Treatment Introduction
    • 11.6.4 Halt Medical, Inc. Revenue in Uterine Fibroid Treatment Business (2015-2020)
    • 11.6.5 Halt Medical, Inc. Recent Development
  • 11.7 LiNA Medical USA
    • 11.7.1 LiNA Medical USA Company Details
    • 11.7.2 LiNA Medical USA Business Overview
    • 11.7.3 LiNA Medical USA Uterine Fibroid Treatment Introduction
    • 11.7.4 LiNA Medical USA Revenue in Uterine Fibroid Treatment Business (2015-2020)
    • 11.7.5 LiNA Medical USA Recent Development
  • 11.8 Merit Medical Systems
    • 11.8.1 Merit Medical Systems Company Details
    • 11.8.2 Merit Medical Systems Business Overview
    • 11.8.3 Merit Medical Systems Uterine Fibroid Treatment Introduction
    • 11.8.4 Merit Medical Systems Revenue in Uterine Fibroid Treatment Business (2015-2020)
    • 11.8.5 Merit Medical Systems Recent Development
  • 11.9 Olympus Corporation
    • 11.9.1 Olympus Corporation Company Details
    • 11.9.2 Olympus Corporation Business Overview
    • 11.9.3 Olympus Corporation Uterine Fibroid Treatment Introduction
    • 11.9.4 Olympus Corporation Revenue in Uterine Fibroid Treatment Business (2015-2020)
    • 11.9.5 Olympus Corporation Recent Development
  • 11.10 Richard Wolf GmbH
    • 11.10.1 Richard Wolf GmbH Company Details
    • 11.10.2 Richard Wolf GmbH Business Overview
    • 11.10.3 Richard Wolf GmbH Uterine Fibroid Treatment Introduction
    • 11.10.4 Richard Wolf GmbH Revenue in Uterine Fibroid Treatment Business (2015-2020)
    • 11.10.5 Richard Wolf GmbH Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Uterine Fibroid Treatment Scope and Market Size
    Uterine Fibroid Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Uterine Fibroid Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Endometrial Ablation
    MRI Guided Procedures
    Hysterectomy
    Myomectomy
    Uterine Artery Embolization
    Radiofrequency Ablation
    Others

    Market segment by Application, split into
    Hospital
    Clinic
    Other

    Based on regional and country-level analysis, the Uterine Fibroid Treatment market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Uterine Fibroid Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Blue Endo
    Boston Scientific Corporation
    CooperSurgical, Inc.
    KARL STORZ SE & Co. KG
    Myovant Sciences (Sumitovant Biopharma Ltd.)
    Halt Medical, Inc.
    LiNA Medical USA
    Merit Medical Systems
    Olympus Corporation
    Richard Wolf GmbH

    Buy now